[1]
“Tolerability and Efficacy of Apixaban Versus Rivaroxaban for Non-Valvular Atrial Fibrillation”, mfm, vol. 33, no. 3, Apr. 2022, Accessed: Oct. 13, 2026. [Online]. Available: http://medicalforummonthly.com/index.php/mfm/article/view/586